7. Psychiatric Emergencies

This page is for educational purposes. Always verify with current clinical guidelines.

Learning Objectives

• Identify the major categories of psychiatric emergencies and the immediate safety priorities for each
• Perform a structured suicide risk assessment and distinguish modifiable from non-modifiable risk factors
• Apply the verbal de-escalation hierarchy before resorting to chemical or physical restraint in acute agitation
• Differentiate serotonin syndrome from neuroleptic malignant syndrome by onset, exam findings, and treatment
• Explain the legal framework for involuntary hospitalization and the limits of patient confidentiality (Tarasoff)
• Recognize catatonia and know why benzodiazepines, not antipsychotics, are first-line treatment

Quick Answer

A psychiatric emergency is any acute disturbance of thought, mood, or behavior that creates an imminent risk to the patient's life or someone else's — suicidal or homicidal crises, severe agitation, acute psychosis, catatonia, and medication-induced syndromes like serotonin syndrome or neuroleptic malignant syndrome (NMS). These situations matter because the window for intervention is narrow: a missed suicide risk assessment or a delayed diagnosis of NMS can be fatal within hours. Management always follows the same sequence — secure safety first (for the patient, staff, and bystanders), rule out a medical cause of the behavioral change, then treat the specific syndrome. Speed and a systematic approach save lives here more than in almost any other area of medicine.

Core Content

1. Suicide Risk Assessment

Suicide is the emergency psychiatry trains you for most rigorously, because it is common, underestimated, and preventable when caught.

How to assess it: Ask directly — "Have you had thoughts of ending your life?" Asking about suicide does not plant the idea or increase risk; avoiding the question only makes you miss it. A structured assessment covers:

• Ideation: passive (wishing to be dead) vs. active (thoughts of acting)
• Plan: specificity and lethality (a plan to jump from a bridge is higher risk than "I might take some pills someday")
• Means: access to firearms, stockpiled medication, or other lethal methods
• Intent: has the patient taken preparatory steps — writing a note, giving away possessions, researching methods?
• Protective factors: children at home, religious beliefs, future-oriented plans, therapeutic alliance

Risk factors that matter clinically: prior suicide attempt (the single strongest predictor), male sex (higher completion rate, though women attempt more often), older age, social isolation, chronic pain, recent psychiatric hospitalization discharge (first week post-discharge is highest risk), substance intoxication, and access to firearms.

Why it matters: Risk assessment isn't a checkbox — it directly determines disposition. High-risk patients (active plan + means + intent) require inpatient admission, by involuntary hold if necessary. Low-risk patients with passive ideation and strong protective factors may be safely managed as outpatients with a safety plan and close follow-up.

Common misunderstanding: Students often think a "no-suicide contract" (having the patient promise not to harm themselves) is a safety intervention. It is not — there is no evidence it reduces suicide, and relying on it can create false reassurance. A collaborative safety plan (identifying warning signs, coping strategies, people to contact, and means restriction) is the evidence-based alternative.

2. Acute Agitation and Aggression

Agitation is a final common pathway for many conditions — psychosis, mania, intoxication, withdrawal, delirium, dementia, or personality-driven crises — so the first job is to figure out why the patient is agitated before deciding how to treat it.

De-escalation comes first. The verbal approach — calm tone, non-threatening body language, giving the patient space and choices, validating their distress — resolves most agitation without medication. Only when this fails, or the patient poses immediate danger, do you escalate to:

1. Oral medication if the patient will accept it (e.g., oral risperidone or lorazepam)
2. Intramuscular medication if refusing but danger is imminent — commonly haloperidol plus lorazepam ("B-52": Benadryl, 5 mg haloperidol, 2 mg lorazepam), or IM olanzapine
3. Physical restraint as a last resort, time-limited, with continuous monitoring and frequent reassessment — never used as punishment or convenience

Why it matters: Jumping straight to restraints without attempting de-escalation is both an ethical and legal problem, and it worsens outcomes — restrained patients have higher rates of injury and psychological trauma. But under-treating a genuinely dangerous patient risks harm to staff and other patients.

Common misunderstanding: Many students assume benzodiazepines alone are always the safest choice for agitation. In agitation from alcohol or benzodiazepine withdrawal, benzodiazepines are correct — but in agitation from intoxication with another sedative, or in an elderly delirious patient, benzodiazepines can worsen confusion and cause paradoxical disinhibition. The choice of agent depends on the underlying cause, not a reflexive default.

3. Acute Psychosis and Catatonia

Acute psychosis (new-onset hallucinations, delusions, or disorganized behavior) is a psychiatric emergency when it drives dangerous behavior — command hallucinations to harm oneself or others, or grossly impaired judgment putting the patient at risk. Before assuming a primary psychotic disorder, always rule out a medical or substance-induced cause: check for fever, altered vital signs, recent drug use, and consider a metabolic and toxicology workup. A first psychotic break in a previously healthy young adult is schizophrenia only after everything else has been excluded.

Catatonia is a distinct motor syndrome — stupor, mutism, waxy flexibility, negativism, posturing, or catatonic excitement — that can occur with psychiatric illness (mood disorders more often than schizophrenia), medical illness, or as a reaction to antipsychotics (which can worsen it).

Why it matters and the key exam trap: the first-line treatment for catatonia is a lorazepam challenge (IV/IM benzodiazepine), not an antipsychotic. Giving an antipsychotic to a catatonic patient can precipitate neuroleptic malignant syndrome or worsen the catatonia. If benzodiazepines fail, electroconvulsive therapy (ECT) is highly effective.

4. Serotonin Syndrome vs. Neuroleptic Malignant Syndrome

These two drug-induced emergencies are frequently confused because both present with altered mental status, autonomic instability, and elevated temperature — but the mechanism, timeline, exam findings, and treatment differ sharply.

Serotonin syndrome results from excess serotonergic activity — classically from combining an SSRI/SNRI with an MAOI, tramadol, triptans, linezolid, or St. John's Wort. Onset is rapid, usually within 24 hours of the offending combination. Exam shows hyperreflexia, myoclonus, and clonus (especially in the lower extremities), tremor, and agitation, on top of hyperthermia and autonomic instability. Treatment: stop the serotonergic agents, supportive care (cooling, IV fluids, benzodiazepines for agitation), and cyproheptadine (a serotonin antagonist) for moderate-severe cases.

Neuroleptic malignant syndrome (NMS) results from dopamine blockade — from antipsychotics (especially high-potency first-generation agents like haloperidol) or abrupt withdrawal of dopaminergic drugs (e.g., in Parkinson's disease). Onset is slower, typically days after starting or increasing the dose. Exam shows "lead-pipe" muscle rigidity and bradyreflexia (decreased or normal reflexes) — the opposite of serotonin syndrome's hyperreflexia. Labs classically show markedly elevated creatine kinase (CK) from muscle breakdown. Treatment: stop the antipsychotic, supportive cooling and hydration, dantrolene (a muscle relaxant) or bromocriptine (a dopamine agonist) for severe cases.

Why it matters: Mistaking one for the other is dangerous — giving an antipsychotic to someone with serotonin syndrome (thinking it's psychiatric agitation) worsens things, and failing to recognize NMS delays dantrolene and cooling, risking rhabdomyolysis, renal failure, and death.

5. Legal and Ethical Framework

Two legal principles come up constantly in psychiatric emergencies:

• Involuntary hospitalization: A patient who is an imminent danger to self or others, or gravely disabled (unable to meet basic needs due to mental illness), can be held against their will for evaluation, typically for 72 hours under state law (e.g., a "5150" hold in California), subject to judicial review for longer commitment.
• Duty to warn/protect (Tarasoff principle): If a patient makes a credible, specific threat against an identifiable third party, the clinician has a duty to take reasonable steps to protect that person — which may include warning them, notifying police, or arranging hospitalization. This is one of the few situations where confidentiality is legally overridden.

Visual Learning: Acute Agitation and Suicide Risk Pathway

Key Terms

Term	Definition	Related Concept
Suicide risk assessment	Structured evaluation of ideation, plan, means, intent, and protective factors to guide disposition	Safety plan, involuntary hold
Safety plan	Collaborative, evidence-based document listing warning signs, coping strategies, contacts, and means restriction	Suicide prevention (replaces no-suicide contracts)
De-escalation	Verbal and behavioral techniques to calm an agitated patient without medication or force	Acute agitation, chemical restraint
Chemical restraint	Use of medication (e.g., haloperidol + lorazepam) to control dangerous behavior when verbal methods fail	Physical restraint, agitation management
Catatonia	Motor syndrome with stupor, mutism, waxy flexibility, or excitement; treated first with benzodiazepines	Lorazepam challenge, ECT
Serotonin syndrome	Toxic excess of serotonergic activity causing hyperreflexia, clonus, myoclonus, and hyperthermia	SSRI-MAOI interaction, cyproheptadine
Neuroleptic malignant syndrome (NMS)	Dopamine-blockade emergency causing lead-pipe rigidity, hyperthermia, and elevated CK	Antipsychotics, dantrolene
Involuntary hospitalization	Legal detention of a patient for psychiatric evaluation without consent when danger criteria are met	Civil commitment, due process
Tarasoff principle	Legal duty to warn or protect an identifiable third party from a credible threat made by a patient	Confidentiality limits, duty to protect
Grave disability	Legal criterion where a person cannot meet basic needs (food, shelter, safety) due to mental illness	Involuntary hold criteria

Common Mistakes

Misconception: Asking a patient directly about suicidal thoughts will "put the idea in their head" or increase their risk. Why it's wrong: Multiple studies show that directly asking about suicide does not increase suicidal ideation or attempts. Avoiding the question only means clinicians miss patients who are already at risk. Correct understanding: Direct, non-judgmental questioning ("Have you thought about ending your life?") is standard of care and often brings relief to patients who were afraid to bring it up themselves.

---

Misconception: Serotonin syndrome and neuroleptic malignant syndrome are basically the same condition with different names. Why it's wrong: They have opposite neuromuscular findings — serotonin syndrome causes hyperreflexia and clonus (especially in the legs), while NMS causes lead-pipe rigidity and reduced reflexes. They also have different mechanisms (serotonergic excess vs. dopamine blockade) and different onset timelines (rapid vs. days). Correct understanding: Distinguish them by drug history (serotonergic combination vs. antipsychotic use), onset speed, and the reflex/tone exam — this changes both diagnosis and treatment (cyproheptadine vs. dantrolene/bromocriptine).

---

Misconception: A catatonic patient who is psychotic should receive an antipsychotic first to control the underlying psychosis. Why it's wrong: Antipsychotics can worsen catatonia and precipitate neuroleptic malignant syndrome in a catatonic patient. Correct understanding: Treat catatonia first with a benzodiazepine (lorazepam challenge); only after catatonia resolves should the underlying psychiatric condition be treated, escalating to ECT if benzodiazepines fail.

Comparison and Connections

Feature	Serotonin Syndrome	Neuroleptic Malignant Syndrome
Mechanism	Excess serotonergic activity	Dopamine receptor blockade
Typical trigger	SSRI/SNRI + MAOI, tramadol, triptans, linezolid	Antipsychotics (especially high-potency), or dopaminergic drug withdrawal
Onset	Rapid (within 24 hours)	Slower (days)
Neuromuscular exam	Hyperreflexia, myoclonus, clonus (lower limbs)	Lead-pipe rigidity, bradyreflexia
Labs	Usually normal or mildly elevated CK	Markedly elevated CK
Treatment	Stop serotonergic drugs, cooling, cyproheptadine	Stop antipsychotic, cooling, dantrolene or bromocriptine

Practice Questions

Recall

1. What are the five components of a structured suicide risk assessment? Guidance: Ideation, plan, means, intent, and protective factors.

2. What is the first-line pharmacologic treatment for catatonia? Guidance: A benzodiazepine, typically IV or IM lorazepam ("lorazepam challenge"). ECT is used if this fails.

Understanding

3. Why is a "no-suicide contract" not considered an evidence-based intervention, and what should replace it? Guidance: No-suicide contracts rely on the patient's promise not to self-harm but have no evidence of reducing suicide risk and can give clinicians false reassurance. A collaborative safety plan — identifying warning signs, coping strategies, support contacts, and restricting access to lethal means — is the evidence-based alternative.

4. Why must de-escalation be attempted before chemical or physical restraint in acute agitation? Guidance: Restraints carry ethical, legal, and clinical risks — injury, trauma, and worse outcomes. Verbal de-escalation resolves most agitation without these risks and is required as the first step unless danger is immediate.

Application

5. A patient on sertraline is started on tramadol for pain and develops agitation, tremor, and clonus in both legs within hours. What is the diagnosis and immediate management? Guidance: Serotonin syndrome from the SSRI-tramadol interaction. Stop both drugs, provide supportive care (cooling, IV fluids), give benzodiazepines for agitation, and use cyproheptadine if moderate-to-severe.

6. A patient with active suicidal ideation, a specific plan to overdose tonight, and pills already gathered at home refuses voluntary admission. What should you do? Guidance: This meets criteria for imminent danger to self; pursue involuntary hospitalization (civil commitment) under state law, since the patient cannot be safely discharged.

Analysis

7. A patient on haloperidol develops rigidity and a fever of 39.5°C three days after a dose increase, with CK markedly elevated. Compare this presentation to serotonin syndrome and explain which diagnosis fits better and why. Guidance: This is NMS, not serotonin syndrome — the trigger is an antipsychotic (dopamine blockade, not serotonergic excess), the onset is delayed (days, not hours), the exam shows rigidity and reduced reflexes (not hyperreflexia/clonus), and CK is markedly elevated, which is far more characteristic of NMS.

8. Explain why the Tarasoff principle represents an exception to standard confidentiality rules, and what factors determine whether it applies. Guidance: Confidentiality is generally absolute in psychiatry, but Tarasoff creates a duty to protect when a patient makes a credible, specific threat against an identifiable victim. Applicability depends on specificity of the threat, identifiability of the victim, and credibility/imminence of danger — vague statements without a specific target usually do not trigger the duty.

FAQ

Q: Does asking about suicide increase the risk that a patient will attempt it? No. Research consistently shows direct questioning about suicidal thoughts does not increase risk and often reduces distress by giving patients permission to disclose what they were already thinking.

Q: How do you tell serotonin syndrome apart from NMS at the bedside? Look at the neuromuscular exam and the timeline. Serotonin syndrome causes hyperreflexia, myoclonus, and clonus with rapid onset after adding a serotonergic drug. NMS causes lead-pipe rigidity and reduced reflexes with slower onset after starting or increasing an antipsychotic, plus a markedly elevated CK.

Q: Why are benzodiazepines first-line for catatonia instead of antipsychotics? Because antipsychotics can worsen catatonia and trigger NMS in these patients. A lorazepam challenge is both diagnostic (dramatic improvement supports the diagnosis) and therapeutic.

Q: What determines whether a patient can be hospitalized against their will? Most jurisdictions require the patient to pose an imminent danger to self or others, or be "gravely disabled" (unable to meet basic survival needs due to mental illness). This typically allows a short involuntary hold (often 72 hours) with judicial review required for longer commitment.

Q: Is IM haloperidol plus lorazepam always the right choice for severe agitation? Not always — the underlying cause matters. It works well for psychotic or manic agitation, but in alcohol/benzodiazepine withdrawal, benzodiazepines alone are preferred, and in elderly delirious patients, both drug classes carry risks (QT prolongation, paradoxical disinhibition) that require caution and lower doses.

Quick Revision

• Suicide risk assessment = ideation + plan + means + intent + protective factors; prior attempt is the strongest single risk factor
• Directly asking about suicide does not increase risk — it is standard of care
• Safety plans (not no-suicide contracts) are the evidence-based intervention for suicidal patients
• Agitation management hierarchy: verbal de-escalation → oral medication → IM medication (haloperidol + lorazepam) → physical restraint (last resort)
• Rule out medical/substance causes before diagnosing a primary psychotic disorder in a first break
• Catatonia: treat first with benzodiazepine (lorazepam challenge); antipsychotics can worsen it and cause NMS; ECT if refractory
• Serotonin syndrome: rapid onset, hyperreflexia/clonus/myoclonus, from serotonergic drug combinations; treat with cyproheptadine
• NMS: delayed onset (days), lead-pipe rigidity, reduced reflexes, markedly elevated CK, from antipsychotics; treat with dantrolene/bromocriptine
• Involuntary hospitalization requires imminent danger to self/others or grave disability
• Tarasoff principle: duty to warn/protect an identifiable victim of a credible threat overrides confidentiality

Related Topics

Prerequisites: Introduction to Psychiatry (DSM-5 framework, mental status exam), basic psychopharmacology, medical ethics and informed consent

Related Topics: Mood Disorders, Psychotic Disorders, Substance Use Disorders, Clinical Psychopharmacology, Consultation-Liaison Psychiatry

Next Topics: Mood Disorders, Psychotic Disorders, Clinical Psychopharmacology